[-] Show simple item record

dc.contributor.authorMcDiarmid, Toddeng
dc.contributor.authorMackler, Leslieeng
dc.date.issued2003eng
dc.description.abstractSystemic corticosteroids improve measures of dyspnea in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) (strength of recommendation [SOR]: A, meta-analysis of 2 small randomized controlled trials). The optimal dose of systemic corticosteroids to achieve these benefits is uncertain. An international consensus panel recommended 30 to 40 mg of oral prednisone daily for 10 to 14 days as a reasonable compromise of efficacy and safety (SOR: C, consensus expert opinion).eng
dc.identifier.urihttp://hdl.handle.net/10355/2938eng
dc.languageEnglisheng
dc.publisherFamily Physicians Inquiries Networkeng
dc.relation.ispartofcollectionClinical Inquiries, 2003 (MU)eng
dc.relation.ispartofcommunityUniversity of Missouri--Columbia. School of Medicine. Department of Family and Community Medicine. Family Physicians Inquiries Networkeng
dc.relation.ispartofseriesJournal of family practice, 52, no. 12 (December 2003)eng
dc.rightsOpenAccess.eng
dc.rights.licenseThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0 License.eng
dc.subjectdyspneaeng
dc.subjectoptimal doseeng
dc.subjectadverse eventseng
dc.subject.lcshDyspneaeng
dc.subject.lcshLungs -- Diseases, Obstructiveeng
dc.subject.lcshRespiratory organs -- Diseaseseng
dc.subject.meshPulmonary Disease, Chronic Obstructiveeng
dc.titleDo systemic corticosteroids lessen symptoms in acute exacerbations of COPD?eng
dc.typeArticleeng


Files in this item

[PDF]

This item appears in the following Collection(s)

[-] Show simple item record